Car
CAR T-Therapy for Multiple Myeloma Patients: Does Race or Ethnicity Impact Outcome?
CAR T-Therapy for Multiple Myeloma Patients: Does Race or Ethnicity Impact Outcome?
Source link
CAR T-Cell Therapy Outcomes Likely Not Influenced by Race/Ethnicity, Obesity
Researchers studied data from 5 phase 1 studies that took place between 2012 and 2021, comprising 139 infusions among patients with B-cell acute ly...
Montefiore Einstein Cancer Center Finds CAR T-Cell Therapy Effective in Black and Hispanic Patients
Investigators at the Montefiore Einstein Cancer Center report that Black and Hispanic patients had outcomes and side effects following CAR-T treatm...
Gilead Sciences's (GILD) Kite Announces Yescarta CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Rega...
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
— Black or Africa...
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
— ...
CAR T-Cell Therapy Is Safe, Effective in Minorities, Study Finds
Investigators from Montefiore Einstein Cancer Center recently published findings from a real-world retrospective cohort study that showed similar e...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
